Waldencast (NASDAQ:WALD – Free Report) had its price target boosted by DA Davidson from $6.50 to $7.25 in a research report released on Wednesday, Benzinga reports. DA Davidson currently has a buy rating on the stock.
Separately, Telsey Advisory Group reduced their price objective on Waldencast from $8.00 to $6.00 and set an outperform rating for the company in a research report on Thursday, August 29th.
Read Our Latest Report on WALD
Waldencast Stock Performance
Institutional Trading of Waldencast
Institutional investors and hedge funds have recently modified their holdings of the business. Marshall Wace LLP bought a new stake in shares of Waldencast in the 2nd quarter worth $37,000. Catalina Capital Group LLC bought a new stake in shares of Waldencast in the 1st quarter worth $73,000. Cubist Systematic Strategies LLC bought a new stake in shares of Waldencast in the second quarter worth $85,000. Norden Group LLC bought a new stake in shares of Waldencast in the first quarter worth $92,000. Finally, Simplicity Wealth LLC bought a new stake in shares of Waldencast in the first quarter worth $142,000. Institutional investors own 41.97% of the company’s stock.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
- Five stocks we like better than Waldencast
- Market Cap Calculator: How to Calculate Market Cap
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Health Care Stocks Explained: Why You Might Want to Invest
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Insider Buying Explained: What Investors Need to Know
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.